ICU Stock Analysis: Buy, Sell, or Hold?
ICU - SeaStar Medical Holding Corporation Common Stock
$4.92
0.06 (1.23%)
▲
5d:
+65.1%
30d:
+39.38%
90d:
+38.2%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ICU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ICU is 26.8% above its trading range ($3.88). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ICU is 26.8% above its trading range ($3.88). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ICU is currently trading at $4.92, which is considered extended relative to its 30-day fair value range of $2.81 to $3.88.
Technical Outlook: Technically, ICU is in a strong uptrend. The price is approaching resistance at $3.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+103.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICU is in a strong uptrend. The price is approaching resistance at $3.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+103.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.81 -
$3.88
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+26.8% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 103.3% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$2.81 -
$3.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.90
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.11
Wall Street Target
$10.00
(+103.3%)
Revenue Growth (YoY)
68.9%
Share & Embed Analysis
Last updated: July 02, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
